As of 12:53:58 PM EST. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| AUDHYA PAUL K Officer | Sale | Nov 26, 2024 | 97,012 |
| CHA ALBERT Director | Sale | Sep 11, 2023 | 0 |
| CROCKETT THOMAS ANDREW Chief Executive Officer | Sale | Feb 20, 2024 | 211,203 |
| FEENER EDWARD P Officer | Sale | May 20, 2024 | 72,858 |
| PALLEIKO BENJAMIN L Chief Executive Officer | Sale | Dec 9, 2024 | 274,596 |
| VENROCK HEALTHCARE CAPITAL PARTNERS II, LP Beneficial Owner of more than 10% of a Class of Security | Purchase | Jan 4, 2024 | -- |
| VENROCK HEALTHCARE CAPITAL PARTNERS III, L.P. Beneficial Owner of more than 10% of a Class of Security | Purchase | Feb 8, 2024 | -- |
| VHCP MANAGEMENT L L C Beneficial Owner of more than 10% of a Class of Security | Purchase | Dec 29, 2023 | -- |
| YEA CHRISTOPHER M Officer | Sale | Nov 26, 2024 | 91,142 |
Related Tickers
DSGN Design Therapeutics, Inc.
4.6950
-7.49%
PRAX Praxis Precision Medicines, Inc.
66.49
-9.77%
PHVS Pharvaris N.V.
17.94
-3.24%
COGT Cogent Biosciences, Inc.
7.76
-4.32%
MRSN Mersana Therapeutics, Inc.
0.8245
-36.58%
SNDX Syndax Pharmaceuticals, Inc.
13.13
-4.92%
STOK Stoke Therapeutics, Inc.
8.91
-0.56%
HLVX HilleVax, Inc.
2.0700
-0.96%
MBX MBX Biosciences, Inc.
13.87
-4.41%
VRDN Viridian Therapeutics, Inc.
18.23
-4.80%